Meurice FP - Search Results

1

Prevalence of hepatitis B surface antigen in vaccinated children and controls in rural Nigeria.

Odusanya OO, Alufohai FE, Meurice FP, Wellens R, Weil J, Ahonkhai VI. Odusanya OO, et al. Among authors: meurice fp. Int J Infect Dis. 2005 May;9(3):139-43. doi: 10.1016/j.ijid.2004.06.009. Int J Infect Dis. 2005. PMID: 15840454 Free article.

2

Determinants of vaccination coverage in rural Nigeria.

Odusanya OO, Alufohai EF, Meurice FP, Ahonkhai VI. Odusanya OO, et al. Among authors: meurice fp. BMC Public Health. 2008 Nov 5;8:381. doi: 10.1186/1471-2458-8-381. BMC Public Health. 2008. PMID: 18986544 Free PMC article.

3

Five-year post vaccination efficacy of hepatitis B vaccine in rural Nigeria.

Odusanya OO, Alufohai E, Meurice FP, Ahonkhai VI. Odusanya OO, et al. Among authors: meurice fp. Hum Vaccin. 2011 Jun;7(6):625-9. doi: 10.4161/hv.7.6.14990. Epub 2011 Jun 1. Hum Vaccin. 2011. PMID: 21508678

4

Short term evaluation of a rural immunization program in Nigeria.

Odusanya OO, Alufohai JE, Meurice FP, Clemens R, Ahonkhai VI. Odusanya OO, et al. Among authors: meurice fp. J Natl Med Assoc. 2003 Feb;95(2):175-9. J Natl Med Assoc. 2003. PMID: 12760613 Free PMC article.

5

Nigerian medical students are at risk for hepatitis B infection.

Odusanya OO, Meurice FP, Hoet B. Odusanya OO, et al. Among authors: meurice fp. Trans R Soc Trop Med Hyg. 2007 May;101(5):465-8. doi: 10.1016/j.trstmh.2006.08.001. Epub 2006 Sep 29. Trans R Soc Trop Med Hyg. 2007. PMID: 17011004

6

Lessons for strengthening childhood immunization in low- and middle-income countries from a successful public-private partnership in rural Nigeria.

Ahonkhai AA, Odusanya OO, Meurice FP, Pierce LJ, Durojaiye TO, Alufohai EF, Clemens R, Ahonkhai VI. Ahonkhai AA, et al. Among authors: meurice fp. Int Health. 2022 Nov 1;14(6):632-638. doi: 10.1093/inthealth/ihab089. Int Health. 2022. PMID: 35039869 Free PMC article.

7

Anamnestic response to administration of purified non-adsorbed hepatitis B surface antigen in healthy responders to hepatitis B vaccine with long-term non-protective antibody titres.

Dentico P, Crovari P, Lai PL, Ponzio F, Safary A, Pellegrino A, Meurice F, Di Pasquale A, Tornieporth N, Volpe A, Icardi G. Dentico P, et al. Vaccine. 2002 Nov 1;20(31-32):3725-30. doi: 10.1016/s0264-410x(02)00356-0. Vaccine. 2002. PMID: 12399201 Clinical Trial.

8

Safety and immunogenicity of an outer surface protein A vaccine in subjects with previous Lyme disease.

Schoen RT, Meurice F, Brunet CM, Cretella S, Krause DS, Craft JE, Fikrig E. Schoen RT, et al. J Infect Dis. 1995 Nov;172(5):1324-9. doi: 10.1093/infdis/172.5.1324. J Infect Dis. 1995. PMID: 7594671 Clinical Trial.

9

Persistence of antibodies in children primed with two different hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type B vaccines and evaluation of booster vaccination.

Tichmann I, Grunert D, Habash S, Preidel H, Schult R, Pfletschinger U, Gildberg PK, Meurice F, Sänger R. Tichmann I, et al. Hum Vaccin. 2006 Nov-Dec;2(6):249-54. doi: 10.4161/hv.2.6.3432. Epub 2006 Nov 27. Hum Vaccin. 2006. PMID: 17106268

10

Comparison of the immunogenicity and reactogenicity of two commercially available hexavalent vaccines administered as a primary vaccination course at 2, 4 and 6 months of age.

Tichmann I, Preidel H, Grunert D, Habash S, Schult R, Maier R, Gildberg PK, Sengespeik HC, Meurice F, Sänger R. Tichmann I, et al. Vaccine. 2005 May 9;23(25):3272-9. doi: 10.1016/j.vaccine.2005.01.087. Vaccine. 2005. PMID: 15837232 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters